Tuberculosis chemotherapy - Still a double-edged sword

被引：8

作者：

Chaisson, RE ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2003年 / 167卷 / 11期

关键词：

D O I：

10.1164/rccm.2303004

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1461 / 1462

页数：2

共 12 条

[1]

[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603

[2]

[Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733

[3] Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners [J].

Chaisson, RE ;

Armstrong, J ;

Stafford, J ;

Golub, J ;

Bur, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :165-166

[4]

DASH LA, 1980, AM REV RESPIR DIS, V121, P1039

[5]

Girling D. J., 1991, American Review of Respiratory Disease, V143, P700

[6] Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial [J].

Jasmer, RM ;

Saukkonen, JJ ;

Blumberg, HM ;

Daley, CL ;

Bernardo, J ;

Vittinghoff, E ;

King, MD ;

Kawamura, LM ;

Hopewell, PC .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (08) :640-647

[7]

KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991

[8] Short-course rifamycin and pyrazinamide treatment for latent tuberculosis infection in patients with HIV infection - The 2-year experience of a comprehensive community-based program in Broward County, Florida [J].

Narita, M ;

Kellman, M ;

Franchini, DL ;

McMillan, ME ;

Hollender, ES ;

Ashkin, D .

CHEST, 2002, 122 (04) :1292-1298

[9] Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic [J].

Nolan, CM ;

Goldberg, SV ;

Buskin, SE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11) :1014-1018

[10]

Porter Roy., 1997, GREATEST BENEFIT MAN

← 1 2 →